scholarly article | Q13442814 |
P50 | author | Fletcher A White | Q59694320 |
Eleni Beli | Q42709533 | ||
Alexander G. Obukhov | Q47151348 | ||
Maria B Grant | Q88523403 | ||
P2093 | author name string | Michael Sturek | |
S Christopher Hiett | |||
Wennan Li | |||
Xingjuan Chen | |||
Saikat Chakraborty | |||
Xin Long | |||
Constance J Temm | |||
Mouhamad Alloosh | |||
Ashley M Riley | |||
P2860 | cites work | Short term effects of spironolactone on blood lipid profile: a 3-month study on a cohort of young women with hirsutism | Q24653568 |
CD40 in coronary artery disease: a matter of macrophages? | Q26752784 | ||
Mineralocorticoid Receptors in the Pathophysiology of Vascular Inflammation and Atherosclerosis | Q26781416 | ||
Immunity, atherosclerosis and cardiovascular disease | Q28688590 | ||
Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition | Q29615691 | ||
Aldosterone inhibition limits collagen synthesis and progressive left ventricular enlargement after anterior myocardial infarction. | Q31795978 | ||
Exercise training decreases store-operated Ca2+entry associated with metabolic syndrome and coronary atherosclerosis | Q33573616 | ||
The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis. | Q33701262 | ||
PKC-dependent Phosphorylation of the H1 Histamine Receptor Modulates TRPC6 Activity | Q33883861 | ||
Coronary artery spasm: review and update | Q34201543 | ||
Mechanisms underlying capsaicin effects in canine coronary artery: implications for coronary spasm | Q34354310 | ||
Higher blood aldosterone level in metabolic syndrome is independently related to adiposity and fasting plasma glucose. | Q34997841 | ||
Bromoenol lactone inhibits voltage-gated Ca2+ and transient receptor potential canonical channels | Q35430018 | ||
Novel Roles for Kv7 Channels in Shaping Histamine-Induced Contractions and Bradykinin-Dependent Relaxations in Pig Coronary Arteries | Q36546867 | ||
Aldosterone increases early atherosclerosis and promotes plaque inflammation through a placental growth factor-dependent mechanism | Q36701794 | ||
Association of metabolic syndrome with coronary atherosclerosis in non-diabetic postmenopausal women. | Q51315653 | ||
Plasma aldosterone is independently associated with the metabolic syndrome. | Q51496145 | ||
The Effect of Spironolactone on Lipid, Glucose and Uric Acid Levels in Blood during Long-Term Administration to Hypertensives | Q51648724 | ||
Role of mast cells in atherosclerosis: a classical inflammatory disease. | Q52977216 | ||
In vivo human MCP-1 transfection in porcine arteries by intravascular electroporation. | Q54641500 | ||
Functional mineralocorticoid receptors in human vascular endothelial cells regulate intercellular adhesion molecule-1 expression and promote leukocyte adhesion | Q37003229 | ||
Upregulated TRPC1 channel in vascular injury in vivo and its role in human neointimal hyperplasia | Q37079233 | ||
Canonical transient receptor potential channels expression is elevated in a porcine model of metabolic syndrome | Q37176258 | ||
Endothelial mineralocorticoid receptor activation mediates endothelial dysfunction in diet-induced obesity | Q37351398 | ||
Identification of canonical transient receptor potential (TRPC) channel proteins in native vascular smooth muscle cells. | Q37411376 | ||
Adventitial nab-rapamycin injection reduces porcine femoral artery luminal stenosis induced by balloon angioplasty via inhibition of medial proliferation and adventitial inflammation | Q37463102 | ||
Macrophages and immune cells in atherosclerosis: recent advances and novel concepts | Q38462573 | ||
TRPC5 channels undergo changes in gating properties during the activation-deactivation cycle | Q38626089 | ||
Emerging Roles of the Mineralocorticoid Receptor in Pathology: Toward New Paradigms in Clinical Pharmacology | Q38669574 | ||
Severe familial hypercholesterolemia impairs the regulation of coronary blood flow and oxygen supply during exercise | Q39394306 | ||
Intravascular ultrasound detection of atherosclerosis at the site of focal vasospasm in angiographically normal or minimally narrowed coronary segments | Q39486793 | ||
FAD286, an aldosterone synthase inhibitor, reduced atherosclerosis and inflammation in apolipoprotein E-deficient mice | Q39668789 | ||
Effect of eplerenone, a selective aldosterone blocker, on blood pressure, serum and macrophage oxidative stress, and atherosclerosis in apolipoprotein E-deficient mice | Q44459362 | ||
Effects of aldosterone on human atherosclerosis: plasma aldosterone and progression of carotid plaque | Q44695581 | ||
Mechanisms involved in spironolactone-induced choleresis in the rat. Role of multidrug resistance-associated protein 2. | Q45225378 | ||
Murine "model" monotheism: an iconoclast at the altar of mouse | Q46643118 | ||
Association of adrenal steroids with hypertension and the metabolic syndrome in blacks | Q46715413 | ||
Molecular Determinants of the Sensitivity to Gq/11-Phospholipase C-dependent Gating, Gd3+ Potentiation, and Ca2+ Permeability in the Transient Receptor Potential Canonical Type 5 (TRPC5) Channel | Q48179404 | ||
Aldosterone, mortality, and acute ischaemic events in coronary artery disease patients outside the setting of acute myocardial infarction or heart failure | Q49106538 | ||
Increased adventitial mast cells in a patient with coronary spasm | Q68943619 | ||
Coronary artery spasm induced in atherosclerotic miniature swine | Q70439239 | ||
Elevation of the plasma histamine concentration in the coronary circulation in patients with variant angina | Q71112099 | ||
Quantitative pharmacologic responses of normal and atherosclerotic isolated human epicardial coronary arteries | Q71250471 | ||
Effect of spironolactone on blood pressure in subjects with resistant hypertension | Q79798622 | ||
Enhancement of receptor-operated cation current and TRPC6 expression in arterial smooth muscle cells of deoxycorticosterone acetate-salt hypertensive rats | Q79918516 | ||
TRP channels in disease | Q79972966 | ||
Arterial stiffness, intima-media thickness and carotid artery fibrosis in patients with primary aldosteronism | Q82603650 | ||
Influence of spironolactone treatment on endothelial function in non-obese women with polycystic ovary syndrome | Q82880351 | ||
Aldosterone, atherosclerosis and vascular events in patients with stable coronary artery disease | Q84444965 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 5 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | metabolic syndrome | Q657193 |
vasoconstriction | Q1067506 | ||
atherosclerosis | Q12252367 | ||
P304 | page(s) | 54 | |
P577 | publication date | 2017-07-29 | |
P1433 | published in | Basic Research in Cardiology | Q2453360 |
P1476 | title | Long-term spironolactone treatment reduces coronary TRPC expression, vasoconstriction, and atherosclerosis in metabolic syndrome pigs | |
P478 | volume | 112 |
Q93037250 | Inhibition of TRPC1 prevents cardiac hypertrophy via NF-κB signaling pathway in human pluripotent stem cell-derived cardiomyocytes |
Q57177158 | Ion Channels and Transporters in Inflammation: Special Focus on TRP Channels and TRPC6 |
Q64078980 | LATS2 overexpression attenuates the therapeutic resistance of liver cancer HepG2 cells to sorafenib-mediated death via inhibiting the AMPK–Mfn2 signaling pathway |
Q64092250 | Melatonin enhances TNF-α-mediated cervical cancer HeLa cells death via suppressing CaMKII/Parkin/mitophagy axis |
Q57750179 | Phenylephrine, a common cold remedy active ingredient, suppresses uterine contractions through cAMP signalling |
Q88959338 | Pyrazolo[1,5-a]pyrimidine TRPC6 antagonists for the treatment of gastric cancer |
Q92258015 | Specific Upregulation of TRPC1 and TRPC5 Channels by Mineralocorticoid Pathway in Adult Rat Ventricular Cardiomyocytes |
Q89468002 | TRPC channels: Structure, function, regulation and recent advances in small molecular probes |
Q61805302 | The TRPC6 inhibitor, larixyl acetate, is effective in protecting against traumatic brain injury-induced systemic endothelial dysfunction |
Search more.